Issue Date: November 30, 2009
Pfizer Plans New China R&D Center
Pfizer has signed a memorandum of understanding with Wuhan National Bioindustry Base to build an R&D center in Wuhan, China. The center in Midwest China will employ 200 people who will initially support clinical drug trials, but ultimately play a role in new drug development. The Wuhan center will supplement Pfizer’s existing Shanghai-based R&D effort, which now employs 350 people.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society